Cell Isolation/Cell Separation Market by Product (Reagents, Beads, Media, Disposables, Centrifuge, Filtration System), Cell Type (Human, Animal), Technology (Filtration, Surface Marker), Application (Research, Therapeutics), End User- Global Forecast to 2024

  • Report ID:MRHC - 104265
  • Pages: 117
  • Apr 2019
  • Formats*: PDF
  • Category: Healthcare

1 Introduction to Cell Isolation/Cell Separation Market
   1.1 Market Ecosystem
   1.2 Definition
   1.3 Years Considered in study
   1.4 Currency and Limitations
   1.5 Market Buzz and Foregrounds

2 Research Methodology

   2.1 Secondary Research
   2.2 Primary Research
   2.3 Market Analytics

3 Executive Summary

4 Market Insights

   4.1 Drivers
         4.1.1 Increasing Incidence & Prevalence of Chronic Diseases with Aging Population
         4.1.2 Technological Advancement in Cell Isolation
         4.1.3 Growing Demand for Biopharmaceuticals and Personalized Medicine
         4.1.4 Increasing Stem Cell Research
   4.2 Restraint
         4.2.1 Ethical Issues Regarding Isolation of Embryonic Stem Cells
         4.2.2 High cost of Cell Separation Instruments
   4.3 Opportunities
         4.3.1 Emerging Opportunities from Asian Countries
         4.3.2 Growing Use of Microfluidics Technology
   4.4 Challenges
         4.4.1 Handling and Optimization of Protocol for in-vitro Study

5 Cell Isolation/Cell Separation Market, by Product

   5.1 Introduction
   5.2 Consumables
         5.2.1 Reagents and Kits
         5.2.2 Beads and Microspheres
         5.2.3 Media and Sera
         5.2.4 Disposables
   5.3 Instruments
         5.3.1 Centrifuges
         Benchtop Centrifuge
         5.3.2 Filtration Systems
         5.3.3 Flow Cytometer
         5.3.4 Magnetic-activated Cell Sorter

6 Cell Isolation/Cell Separation Market, by Cell Type
   6.1 Introduction
   6.2 Human Cells
         6.2.1 Bone Marrow
         6.2.2 Adipose Tissue
         6.2.3 Cord Blood/Embryonic Stem Cells
   6.3 Animal Cells
         6.3.1 Bone Marrow
         6.3.2 Adipose Tissue
         6.3.3 Cord Blood/Embryonic Stem Cells
   6.4 Plant Cells
   6.5 Others

7 Cell Isolation/Cell Separation Market, by Technology
   7.1 Introduction
   7.2 Centrifugation Based Cell Separation
   7.3 Filtration Based Cell Separation
   7.4 Surface Marker Cell Isolation

8 Cell Isolation/Cell Separation Market, by Application
   8.1 Introduction
   8.2 Isolation of Biomolecules
   8.3 Research
         8.3.1 Cancer Research
         8.3.2 Stem Cell Research
   8.4 Diagnostics
   8.5 Therapeutics
   8.6 Others

9 Cell Isolation/Cell Separation Market, by End User
   9.1 Introduction
   9.2 Pharmaceutical & Biotechnology Companies
   9.3 Hospitals and Diagnostic Labs
   9.4 Academic and Research Institutes
   9.5 Cell Banks

10 Cell Isolation/Cell Separation Market, by Geography
     10.1 Introduction
     10.2 North America
             10.2.1 U.S.
             10.2.2 Canada
     10.3 Europe
             10.3.1 Germany
             10.3.2 France
             10.3.3 U.K.
             10.3.4 Italy
             10.3.5 Spain
             10.3.6 RoE
     10.4 Asia-Pacific
             10.4.1 Japan
             10.4.2 China
             10.4.3 India
             10.4.4 RoAPAC
     10.5 Rest of World
             10.5.1 Latin America
             10.5.2 Middle East & Africa

11 Competitive Landscape

12 Company Profiles

     12.1 Thermo Fisher Scientific Inc.
     12.2 GE Healthcare
     12.3 Bio-Rad Laboratories
     12.4 Merck KGaA
     12.5 Becton, Dickinson and Company
     12.6 Miltenyi Biotec
     12.7 Beckman Coulter Inc. (Subsidiary of Danaher Corporation)
     12.8 Terumo Bct, Inc.
     12.9 pluriSelect Life Science
     12.10 Stemcell Technologies Inc.
     12.11 Takara Bio Inc.

13 Appendix
13.1 Questionnaire

Cell isolation or separation is a tool used to sort cells into specific population from heterogeneous group of cells without contamination. The isolation of cells depends on properties of cells such as surface charge and adhesion, cell size and density, surface markers, and few others. The use of cell isolation techniques helps to open the door of cell-based therapies and thereby improve the quality of treatment and clinical outcome. Factors such as increasing incidence & prevalence of chronic diseases with aging population, technological advancement in cell isolation, growing demand for biopharmaceuticals and personalized medicine, and increasing stem cell research are driving cell isolation/cell separation market. Moreover, Asian countries and growing use of microfluidics technology will provide high opportunities for this market during forecast period. On the other hand, ethical issues regarding isolation of embryonic stem cells and high cost of cell separation instruments are expected to restrict the growth of this market.

Key Players in the Cell Isolation/Cell Separation Market

Vendors are moving towards launching of new products along with technological advancement. For instance, in April 2018, Merck KGaA (Germany) launched CellStream benchtop flow cytometry system. This system provides greater sensitivity and allows scientists to tailor their instrument to their needs in immunology, cancer research and many other areas. Moreover, in 2016, QIAGEN N.V. launched QIAscout for isolation of viable single cells from samples for next-generation sequencing (NGS), polymerase chain reaction (PCR) and other downstream applications.

Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.S.), Bio-Rad Laboratories Inc. (U.S.), Merck KGaA (Germany), Miltenyi Biotec (Germany), Becton, Dickinson and Company (U.S.), Beckman Coulter Inc. (U.S.), Terumo BCT, Inc. (U.S.), STEMCELL Technologies Inc. (Canada), pluriSelect Life Science UG & Co. KG (Germany), and Takara Bio Inc. (Japan) are some of the key players operating in this market.

Potential Market Analysis

The cell isolation/cell separation market is segmented by product [consumables (reagents and kits, beads and microspheres, media and sera, disposables), instruments (centrifuges, filtration systems, flow cytometer, magnetic-activated cell sorter)], cell type (human cells, animal cells, and others), technology (centrifugation, filtration, surface marker cell isolation), application (isolation of biomolecules, research, diagnostics, therapeutics, and others), end user (pharmaceutical & biotechnology companies, hospitals and diagnostic labs, academic and research institutes, and cell banks), and geography.

Based on product, consumables accounted for the largest share of global cell isolation/cell separation market in 2018 due to their repeated usage and procurement for various applications such as research, diagnostics, therapeutics, and others.

On the basis of cell type, human cells are expected to grow at fastest rate owing to growing number of chronic diseases and advancement in cell isolation techniques.

Based on application, isolation of biomolecules accounted for the largest share of global cell isolation/cell separation market in 2018. This is mainly due to increasing investment in biopharmaceutical production and personalized medicines by various end users.

On the basis of geographical analysis, North America including U.S. and Canada is anticipating being the largest market due to well-established healthcare system in the region, higher acceptance of advanced technologies, raising non-communicable diseases, rise in pharmaceutical & biotech research, higher stem cell research funding, and presence of key players. Moreover, Asia Pacific is expected to grow at fastest CAGR due to rapidly developing economies, growing aging population coupled with the rising prevalence of chronic diseases, on-going capacity expansions by pharmaceutical & biotechnology manufacturers, and investment from government & non-government bodies in biotechnology sector.

Potential of Market

Stem cell based research is continuously growing by passing various hurdles. Moreover, researchers have been scaled back their use of animal models as these stem cells give better path for studying human diseases. The cell based diagnostic tool offers a more accurate representation of the real-life model than animal-based model. Also, it reduces the time span and expenses in drug discovery compared to animal-based diagnosis. Thus, their potential will lead to reshape the biological concepts and start to move them into clinic within next few years.

Report Name
Full Name
Job Title
Phone Number
Your Specific Interest
This website is secure and we do not share your personal information with any third party. Privacy Policy
Tags: Healthcare Biotechnology Analytial Instrumentation Animal Health Automated Instrumentation Reagents and Kits
Download Free Sample